NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA) announced today that its Cogenics division, a worldwide leader in genomics services, has partnered with SinoGenoMax Co. Ltd., broadening its clinical genotyping service to include the large and growing market in China. Cogenics has a long and successful track record of applying a wide variety of genotyping platforms and counts among its customers the top 20 pharmaceutical companies operating in the U.S. and Europe.
